Immuneering
Price & Volume
Stats
See moreOpen | $5.13 |
Previous Close | $5.14 |
Day Range | $5.02-$5.25 |
52W Range | $1.40-$10.08 |
Market Cap | $330.5M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $455 |
Revenue Growth (YoY) | -99.8% |
Gross Profit (12 Mos) | $158,830 |
Diluted EPS | -$1.27 |
News
See moreYahoo Finance • last month
Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings
Yahoo Finance • last month
Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference
Yahoo Finance • 2 months ago
Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival
Yahoo Finance • 5 months ago
Immuneering Prepares To Share 12-Month Survival Data In Pancreatic Cancer Trial
About
CEO | Dr. Benjamin J. Zeskind M.B.A., Ph.D. |
Address | 245 Main Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 53 |